Quantitative risk assessment for multivariate continuous outcomes with application to neurotoxicology: The bivariate case

被引:8
作者
Yu, ZF
Catalano, PJ
机构
[1] Stat Collaborat Inc, Washington, DC 20036 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
关键词
benchmark dose; dose-response modeling; multiple outcomes; percentile regression;
D O I
10.1111/j.1541-0420.2005.00350.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The neurotoxic effects of chemical agents are often investigated in controlled studies on rodents, with multiple binary and continuous endpoints routinely collected. One goal is to conduct quantitative risk assessment to determine safe dose levels. Such studies face two major challenges for continuous outcomes. First, characterizing risk and defining a benchmark dose are difficult. Usually associated with an adverse binary event, risk is clearly definable in quantal settings as presence or absence of an event; finding a similar probability scale for continuous outcomes is less clear. Often, an adverse event is defined for continuous outcomes as any value below a specified cutoff level in a distribution assumed normal or log normal. Second, while continuous outcomes are traditionally analyzed separately for such studies, recent literature advocates also using multiple outcomes to assess risk. We propose a method for modeling and quantitative risk assessment for bivariate continuous outcomes that address both difficulties by extending existing percentile regression methods. The model is likelihood based; it allows separate dose-response models for each outcome while accounting for the bivariate correlation and overall characterization of risk. The approach to estimation of a benchmark dose is analogous to that for quantal data without the need to specify arbitrary cutoff values. We illustrate our methods with data from a neurotoxicity study of triethyl tin exposure in rats.
引用
收藏
页码:757 / 766
页数:10
相关论文
共 24 条
[11]   Quantalization of continuous data for benchmark dose estimation [J].
Gaylor, DW .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1996, 24 (03) :246-250
[12]   DOSE-RESPONSE ASSESSMENTS FOR DEVELOPMENTAL TOXICITY .4. BENCHMARK DOSES FOR FETAL WEIGHT CHANGES [J].
KAVLOCK, RJ ;
ALLEN, BC ;
FAUSTMAN, EM ;
KIMMEL, CA .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1995, 26 (02) :211-222
[13]   NEUROTOXICITY MODELING FOR RISK ASSESSMENT [J].
KODELL, RL ;
CHEN, JJ ;
GAYLOR, DW .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 22 (01) :24-29
[14]   UPPER CONFIDENCE-LIMITS ON EXCESS RISK FOR QUANTITATIVE RESPONSES [J].
KODELL, RL ;
WEST, RW .
RISK ANALYSIS, 1993, 13 (02) :177-182
[15]  
Moser VC, 1997, NEUROTOXICOLOGY, V18, P929
[16]  
MOSER VC, 1992, J AM COLL TOXICOL, V10, P661
[17]   PERCENTILE REGRESSION-ANALYSIS OF CORRELATED ANTIBODY-RESPONSES [J].
MOULTON, LH ;
HOLT, EA ;
JOB, JS ;
HALSEY, NA .
STATISTICS IN MEDICINE, 1995, 14 (08) :777-787
[18]   ASYMMETRIC LEAST-SQUARES ESTIMATION AND TESTING [J].
NEWEY, WK ;
POWELL, JL .
ECONOMETRICA, 1987, 55 (04) :819-847
[19]  
Rees D. Cooper, 1994, P275
[20]   Likelihood models for clustered binary and continuous outcomes: Application to developmental toxicology [J].
Regan, MM ;
Catalano, PJ .
BIOMETRICS, 1999, 55 (03) :760-768